Dr. Reddy's Teraleve® 4mg and 8mg Fesoterodine Fumarate Prolonged-Release tablets have been available in the UK since their launch on 1st June 2022.
Therapeutic indications:
Indicated in adults for treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur with overactive bladder
syndrome.
Presentation:
4mg tablets are light blue, oval, biconvex, film-coated, and engraved on one side with the number '4'.
8mg tablets are light blue, oval, biconvex, film-coated, and engraved on one side with the number '8'.
Tablets are packaged in aluminium-aluminium blisters in a carton with a PIL.